Inventor
SUBASINGHE NALIN L
US13 patents
⚠️ This page may combine multiple inventors who share the name “SUBASINGHE NALIN L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DIMENSIONAL PHARM INC
7 patentsUS5741819AApr 21, 1998
Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
DIMENSIONAL PHARM INC57 citations96
US6562840B1May 13, 2003
Heteroaryl amidines, methylamidines and guanidines, and the use thereof as protease inhibitors
DIMENSIONAL PHARM INC16 citations92
US6403633B2Jun 11, 2002
Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitors
DIMENSIONAL PHARM INC21 citations92
US6291514B1Sep 18, 2001
Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
DIMENSIONAL PHARM INC15 citations92
US6515002B2Feb 4, 2003
Compounds and compositions for treating C1s-mediated diseases and conditions
DIMENSIONAL PHARM INC26 citations90
US6492403B1Dec 10, 2002
Methods of treating C1s-mediated diseases and conditions and compositions thereof
DIMENSIONAL PHARM INC22 citations90
US5612369AMar 18, 1997
Thrombin inhibitors
DIMENSIONAL PHARM INC16 citations71
JANSSEN PHARMACEUTICA NV
4 patentsUS11254647B2Feb 22, 2022
Benzo-fused heterocyclic derivatives useful as agonists of GPR120
JANSSEN PHARMACEUTICA NV0 citations62
US10730847B2Aug 4, 2020
Benzo-fused heterocyclic derivatives useful as agonists of GPR120
JANSSEN PHARMACEUTICA NV0 citations52
US7868023B2Jan 11, 2011
Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions
JANSSEN PHARMACEUTICA NV0 citations47
US7385066B2Jun 10, 2008
Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions
JANSSEN PHARMACEUTICA NV0 citations47